Cor Vasa 2008, 50(5):207-214 | DOI: 10.33678/cor.2008.069

Ventricular assist devices in the management of terminal heart failure

Ivan Netuka, Jiří Malý, Ondrej Szárszoi
Klinika kardiochirurgie, Institut klinické a experimentální medicíny, Praha, Česká republika

Ventricular assist devices are currently one of the most dynamically evolving fields of modern cardiology and cardiac surgery. In heart transplantation, they have become a routine and effective method, which allows bridging the critically failing patient to the time until a suitable donor heart becomes available. Technical innovation has expanded their potential utility to new areas of indication; there has also been a substantial shift in terms of their service life and user friendliness to the patient including the possibility of outpatient therapy. The article presents, in a broader context, the classification of systems with attention to their proper choice as part of a summary of indications and contraindications. The most common complications associated with the use of ventricular assist devices are also discussed. Furthermore, the article describes the techniques of device implantation and systematic postoperative care of the patient. Finally, the experience gained to date by the authors in this area is reviewed.

Keywords: Ventricular assist device; Bridge to transplantation; Terminal heart failure

Published: May 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Netuka I, Malý J, Szárszoi O. Ventricular assist devices in the management of terminal heart failure. Cor Vasa. 2008;50(5):207-214. doi: 10.33678/cor.2008.069.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005;112:e154-e235. Go to original source...
    2. Akutsu T, Kolff W. Permanent substitutes for valves and heart. Trans Am Soc Artific Intern Organs 1958;4:230.
    3. De Vries W. Clinical use of the total artificial heart. N Engl J Med 1984;310:273-8. Go to original source... Go to PubMed...
    4. Vašků J, Černý J, Dostál M, et al. Comparative study of the implantation of a hybrid total artificial heart (TAH) TNS-BRNO-II and TNS-BRNO-VII. Life Support Syst 1985;3 (Suppl 1):211-4. Go to PubMed...
    5. Farrar DJ, Hill JD, Pennington DG, et al. Preoperative and postoperative comparison of patients with univentricular and biventricular support with the thoratec ventricular assist device as a bridge to cardiac transplantation. J Thorac Cardiovasc Surg 1997;113:202-9. Go to original source... Go to PubMed...
    6. Slaughter MS, Tsui SS, El-Banayosy A, et al. Results of a multicenter clinical trial with the Thoratec implantable ventricular assist device. J Thorac Cardiovasc Surg 2007;133:1573-80. Go to original source... Go to PubMed...
    7. Wieselthaler GM, Schima H, Hiesmayr M, et al. First clinical experience with the DeBakey VAD continuous-axial-flow pump for bridge to transplantation. Circulation 2000;101:356-9. Go to original source...
    8. Thalmann M, Schima H, Wiesenthaler G, Wolner E. Physiology of continuous blood flow in recipients of rotary cardiac assist devices. J Heart Lung Transplant 2005;24:237-45. Go to original source... Go to PubMed...
    9. Haft J, Armstrong W, Dyke DB, et al. Hemodynamic and exercise performance with pulsatile and continuous-flow left ventricular assist devices. Circulation 2007; 116 (Suppl):I8-I15. Go to original source... Go to PubMed...
    10. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001;345:1435-43. Go to original source... Go to PubMed...
    11. Westaby S, Frazier OH, Banning A, et al. Six years of continuous mechanical circulatory support. N Engl J Med 2006;355:325-7. Go to original source... Go to PubMed...
    12. Oz MC, Argenziano M, Catanese KA, et al. Bridge experience with long-term implantable left ventricular assist devices. Are they an alternative to transplantation? Circulation 1997;95:1844-52. Go to original source...
    13. Stevenson LW, Rose EA. Left ventricular assist devices: bridges to transplantation, recovery, and destination for whom? Circulation 2003;108:3059-63. Go to original source... Go to PubMed...
    14. Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007;357:885-96. Go to original source... Go to PubMed...
    15. Frazier OH, Rose EA, McCarthy P, et al. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Ann Surg 1995;222:327-36. Go to original source... Go to PubMed...
    16. Farrar DJ, Holman WR, McBride LR, et al. Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. J Heart Lung Transplant 2002;21:516-21. Go to original source... Go to PubMed...
    17. Hall JL, Birks EJ, Grindle S, et al. Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy. Eur Heart J 2007;28:613-27. Go to original source... Go to PubMed...
    18. Birks EJ, Tansley PD, Hardy J, et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 2006;355:1873-84. Go to original source... Go to PubMed...
    19. John R, Liao K, Lietz K, et al. Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. J Thorac Cardiovasc Surg 2007;134:351-8. Go to original source... Go to PubMed...
    20. Frazier OH, Rose EA, Oz MC, et al. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg 2001;122: 1186-95. Go to original source... Go to PubMed...
    21. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001;345:1435-43. Go to original source... Go to PubMed...
    22. Lietz K, Long JW, Kfoury AG, et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 2007;116:497-505. Go to original source... Go to PubMed...
    23. Haddad H, Elabbassi W, Moustafa S, et al. Left ventricular assist devices as bridge to heart transplantation in congestive heart failure with pulmonary hypertension. ASAIO J 2005;51:456-60. Go to original source... Go to PubMed...
    24. Salzberg SP, Lachat ML, Von Harbou K, Zund G, Turina MI. Normalization of high pulmonary vascular resistance with LVAD support in heart transplantation candidates. Eur J Cardiothorac Surg 2005;27:222-5. Go to original source... Go to PubMed...
    25. Martin J, Siegenthaler MP, Friesewinkel O, et al. Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation-a preliminary study. Eur J Cardiothorac Surg 2004;25:971-7. Go to original source... Go to PubMed...
    26. Zimpfer D, Zrunek P, Roethy W, et al. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates. J Thorac Cardiovasc Surg 2007;133:689-95. Go to original source... Go to PubMed...
    27. Zimpfer D, Zrunek P, Sandner S, et al. Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices. Eur J Cardiothorac Surg 2007;31:698-702. Go to original source... Go to PubMed...
    28. Drakos SG, Stringham JC, Long JW, et al. Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusions. J Thorac Cardiovasc Surg 2007;133:1612-9. Go to original source... Go to PubMed...
    29. Drakos SG, Kfoury AG, Long JW, et al. Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients. Ann Thorac Surg 2006;82:889-93. Go to original source... Go to PubMed...
    30. Kettner J. Mechanické podpory krevního oběhu. Cor Vasa 2003;45:437-43.
    31. Kettner J, Pirk J, Netuka I, et al. Mechanical cardiac support-the first use in Czech Republic. Čas Lék čes 2005;144:38-42.
    32. Kettner J, Pirk J, Netuka I, et al. První použití mechanické srdeční podpory v České republice. Interv Akut Kardiol 2004;2:4-6

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes